Neopharma Company
![](/files/companies/Neopharma.png)
Neopharma commenced operations in 2003 and the first set of manufacturing facilities were planned on an investment outlay of USD25 million. The organization’s inspiration stems from the vision to locally manufacture world class pharmaceuticals at affordable prices. Neopharmas global presence is supported by 10 manufacturing facilities spread across 3 continents delivering branded and generic formulations, and active pharmaceutical ingredients (APIs).
Industry:
Pharmaceuticals
Headquarters:
Abu Dhabi, Abu Dhabi, United Arab Emirates